Literature DB >> 33370300

Implementation challenges and opportunities for improved mass treatment uptake for lymphatic filariasis elimination: Perceptions and experiences of community drug distributors of coastal Kenya.

Doris W Njomo1, Bridget W Kimani1, Lydiah W Kibe1, Collins Okoyo1, Wyckliff P Omondi2, Hadley M Sultani2.   

Abstract

Community drug distributors (CDDs) who are volunteers have the responsibility of awareness creation, household census, drug distribution and record-keeping and are thus key stakeholders in the campaign for Lymphatic Filariasis (LF) elimination. Taking into account their experiences and perceptions is important for a successful elimination campaign. We conducted a qualitative study in 2018 to identify implementation challenges and opportunities for improved mass drug administration (MDA) uptake based on the CDDs perceptions and experiences. Within a larger study that used mixed methods quasi-experimental design, we collected qualitative data from two wards in Kaloleni Sub-County of Kilifi County which was purposively selected owing to its low, 56% and 50.5% treatment coverage in 2015 and 2016 respectively. Focus group discussions (FGDs) (n = 8) and in-depth interviews (IDIs) (n = 8) with CDDs, IDIs (n = 22) with opinion leaders and IDIs (n = 8) with health workers were conducted and the data analyzed by QSR NVIVO version 10 according to thematic areas. The results showed that based on the perceptions and experiences of the CDDs, several challenges: communities' refusal to take the drugs; absenteeism during MDA; non-adherence to CDDs selection criteria; inadequacy in number of CDDs engaged during the campaign and training provided; insufficiency of drugs issued to CDDs; lack of CDDs supervision and low motivation negatively impact on MDA uptake. Opportunities to address the challenges included: awareness creation on MDA, health education on LF and observation of hygiene during drug administration, increased duration of awareness creation and drug administration, adherence to CDDs selection criteria and putting into consideration the vastness of an area and population density while deploying CDDs. Other opportunities include: improved CDDs training and scheduling; issuing of enough drugs to CDDs to meet the communities' demand and improved supervision and motivation of CDDs. Addressing the challenges highlighted is an important step of maximizing MDA uptake. The opportunities presented need to be considered by the NTD program personnel, the county health personnel and the community while planning the implementation of MDA campaigns.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33370300      PMCID: PMC7793263          DOI: 10.1371/journal.pntd.0009012

Source DB:  PubMed          Journal:  PLoS Negl Trop Dis        ISSN: 1935-2727


  30 in total

1.  Factors influencing drug compliance in the mass drug administration programme against filariasis in the Western province of Sri Lanka.

Authors:  Sharmini Gunawardena; Mahroof Ismail; Mark Bradley; Nadira Karunaweera
Journal:  Trans R Soc Trop Med Hyg       Date:  2006-11-27       Impact factor: 2.184

2.  Improving community participation to eliminate lymphatic filariasis in American Samoa.

Authors:  Jonathan D King; Emily Zielinski-Gutierrez; Molisamoa Pa'au; Patrick Lammie
Journal:  Acta Trop       Date:  2010-10-30       Impact factor: 3.112

3.  Prospects for elimination of bancroftian filariasis by mass drug treatment in Pondicherry, India: a simulation study.

Authors:  Wilma A Stolk; Subramanian Swaminathan; Gerrit J van Oortmarssen; P K Das; J Dik F Habbema
Journal:  J Infect Dis       Date:  2003-10-31       Impact factor: 5.226

4.  Factors Associated with Ivermectin Non-Compliance and Its Potential Role in Sustaining Onchocerca volvulus Transmission in the West Region of Cameroon.

Authors:  Laura Senyonjo; Joseph Oye; Didier Bakajika; Benjamin Biholong; Afework Tekle; Daniel Boakye; Elena Schmidt; Elizabeth Elhassan
Journal:  PLoS Negl Trop Dis       Date:  2016-08-16

5.  Profiling the best-performing community medicine distributors for mass drug administration: a comprehensive, data-driven analysis of treatment for schistosomiasis, lymphatic filariasis, and soil-transmitted helminths in Uganda.

Authors:  Goylette F Chami; Narcis B Kabatereine; Edridah M Tukahebwa
Journal:  BMC Med       Date:  2019-03-28       Impact factor: 8.775

6.  A success story: Togo is moving toward becoming the first sub-Saharan African nation to eliminate lymphatic filariasis through mass drug administration and countrywide morbidity alleviation.

Authors:  Yao K Sodahlon; Ameyo Monique Dorkenoo; Kodjo Morgah; Komlan Nabiliou; Kossivi Agbo; Rebecca Miller; Michel Datagni; Anders Seim; Els Mathieu
Journal:  PLoS Negl Trop Dis       Date:  2013-04-11

7.  Factors determining noncompliance to mass drug administration for lymphatic filariasis elimination.

Authors:  Zinia T Nujum; S Remadevi; C Nirmala; K Rajmohanan; Ps Indu; S Muraleedharan Nair
Journal:  Trop Parasitol       Date:  2012-07

8.  Assessment of lymphatic filariasis prior to re-starting mass drug administration campaigns in coastal Kenya.

Authors:  Sammy M Njenga; Henry M Kanyi; Faith M Mutungi; Collins Okoyo; Hadley S Matendechero; Rachel L Pullan; Katherine E Halliday; Simon J Brooker; C Njeri Wamae; Joyce K Onsongo; Kimberly Y Won
Journal:  Parasit Vectors       Date:  2017-02-22       Impact factor: 3.876

Review 9.  Review of the factors influencing the motivation of community drug distributors towards the control and elimination of neglected tropical diseases (NTDs).

Authors:  Alison Krentel; Margaret Gyapong; Shruti Mallya; Nana Yaa Boadu; Mary Amuyunzu-Nyamongo; Mariana Stephens; Deborah A McFarland
Journal:  PLoS Negl Trop Dis       Date:  2017-12-06

10.  Ensuring no one is left behind: Urgent action required to address implementation challenges for NTD control and elimination.

Authors:  Alison Krentel; Margaret Gyapong; Olumide Ogundahunsi; Mary Amuyunzu-Nyamongo; Deborah A McFarland
Journal:  PLoS Negl Trop Dis       Date:  2018-06-07
View more
  3 in total

1.  Defining optimal implementation packages for delivering community-wide mass drug administration for soil-transmitted helminths with high coverage.

Authors:  Marie-Claire Gwayi-Chore; Kumudha Aruldas; Euripide Avokpaho; Chawanangwa Maherebe Chirambo; Saravanakumar Puthupalayam Kaliappan; Parfait Houngbégnon; Comlanvi Innocent Togbevi; Félicien Chabi; Providence Nindi; James Simwanza; Jabaselvi Johnson; Edward J Miech; Khumbo Kalua; Moudachirou Ibikounlé; Sitara S R Ajjampur; Bryan J Weiner; Judd L Walson; Arianna Rubin Means
Journal:  BMC Health Serv Res       Date:  2022-06-18       Impact factor: 2.908

Review 2.  Community views on mass drug administration for filariasis: a qualitative evidence synthesis.

Authors:  Melissa Taylor; Rebecca Thomas; Sandy Oliver; Paul Garner
Journal:  Cochrane Database Syst Rev       Date:  2022-02-17

3.  Towards elimination of Lymphatic Filariasis in Kenya: improving advocacy, communication and social mobilization activities for mass drug administration, a qualitative study.

Authors:  Lydiah W Kibe; Bridget W Kimani; Collins Okoyo; Wyckliff P Omondi; Hadley M Sultani; Doris W Njomo
Journal:  Trop Dis Travel Med Vaccines       Date:  2022-06-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.